Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion type Assertion NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_head.
- NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion description "[The HF pharmacogenetic literature is still in its very early stages, but there are promising candidate genetic variants that may identify which HF patients are most likely to benefit from beta-blockers and ACE inhibitors and patients that may require additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_provenance.
- NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion evidence source_evidence_literature NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_provenance.
- NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion SIO_000772 25150872 NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_provenance.
- NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion wasDerivedFrom befree-2016 NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_provenance.
- NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_assertion wasGeneratedBy ECO_0000203 NP1213137.RAzFhxqyb7bT7a1Xiwd3LhjdxUD91j1KxgoxKQkoiVQyQ130_provenance.